| abstract |
COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING A MAMMAL, SUFFERING FROM A DISEASE OR CONDITION INVOLVING MONOAMINE RECEIVER, OR DISTURBUS RELATED TO A COMPONENT MACHINERY, OF A COMPOUND FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A DISEASE OR CONDITION INVOLVING MONOAMINE RECEIVER OR DISORDER RELATED TO AND USE OF A COMPOUND FOR THE PREPARATION OF A MEDICINAL PRODUCTS FOR THE TREATMENT OF MONOAMINE medical uses of novel pharmaceutically acceptable salt monoamine transfer inhibitors and their prodrugs in the treatment and / or management of psychotropic disorders, anxiety disorder, generalized anxiety disorder, depression, posttraumatic stress disorder, obsessive compulsive disorder disturbance panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, painful diabetic retinopathy, bipolar depression, obstructive sleep apnea, psychiatric disorders, premenstrual dysphoric disorder, social phobia, disorder social anxiety, urinary incontinence, anorexia, bulimia nervosa, obesity, ischemia, head injury, calcium overload in brain cells, chemical dependence, and / or premature ejaculation. |